Outsourcing | 17/05/2022 | By Content editor | 702
Glenmark's subsidiary, Ichnos Sciences signs licensing pact with Almirall
Glenmark's 100% subsidiary Ichnos Sciences Inc., a global biotechnology company developing innovative biologics in oncology and autoimmune diseases, and Almirall S.A, a global biopharmaceutical company focused on skin health, announced today that they have entered into an exclusive licensing agreement for the IL-1RAP antagonist ISB 880
Outsourcing | 14/12/2021 | By Darshana | 764
Natco Pharma's partner Breckenridge Pharma launches generic Afinitor in US market
Natco Pharma Limited announced that its marketing partner Breckenridge Pharmaceutical, Inc., US has launched the 10mg strength of everolimus tablets (generic for Afinitor) in the US market
Outsourcing | 01/10/2021 | By Darshana | 611
ICMR invites proposals for providing clinical trials liability insurance for SOLIDARITY PLUS trial
ICMR through ICMR-National AIDS Research Institute, Pune is coordinating a trial, titled "An international randomized trial of additional treatments for Covid-19 in hospitalized patients who are all receiving the local standard of care SOLIDARITY TRIAL PLUS" or World Health Organization (WHO)-India (ICMR) SOLIDARITY trial plus
Outsourcing | 27/08/2021 | By Darshana | 633
The Department of Pharmaceuticals (DoP) has extended the timeline for submission of applications under the production linked incentive scheme for promotion of domestic manufacturing of critical key starting materials (KSMs) or drug intermediates and active pharmaceutical ingredients (API) and medical devices, till August 31, 2021
Outsourcing | 30/07/2021 | By Darshana | 569
In a bid to enhance market access for Indian pharmaceuticals, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) has asked its member companies to furnish details of market access issues and non-tariff measures (NTMs) being faced them while exporting to countries like United States of America, European Union, Japan, Australia, Brazil
Outsourcing | 15/07/2021 | By Darshana | 540
VectorBuilder a global leader in vector design, optimization and GMP manufacturing has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production
Outsourcing | 06/07/2021 | By Darshana | 486
DRDO invites EoI to transfer technology of 2-DG drug for bulk production
The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of Covid-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industries for production
Outsourcing | 10/06/2021 | By Darshana | 348
Today, the U.S. Food and Drug Administration is providing an update on adverse events reported to the Agency related to breast implants, including breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), and systemic signs and symptoms referred to by patients as breast implant illness (BII), which some patients report after receiving breast
Outsourcing | 21/08/2020 | By Darshana | 867
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy